G9Pharma Co Ltd
KOSDAQ:078650
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
G9Pharma Co Ltd
KOSDAQ:078650
|
KR |
|
B
|
Black Sea Property AS
OSE:BSP
|
NO |
|
K
|
K&S AG
DUS:SDF
|
DE |
|
Transition SA
F:99S
|
FR |
|
Boadicea Resources Ltd
ASX:BOA
|
AU |
|
T
|
Tali Digital Ltd
XMUN:UV7
|
AU |
|
S
|
Stark Focus Group Inc
OTC:SKFG
|
CA |
|
A
|
AJ Plast PCL
SET:AJ
|
TH |
|
T
|
Telemasters Holdings Ltd
JSE:TLM
|
ZA |
|
F
|
Fairchild Gold Corp
XTSX:FAIR
|
CA |
|
White River Bancshares Co
OTC:WRIV
|
US |
Dividends
Dividend Yield
G9Pharma Co Ltd
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
G9Pharma Co Ltd
Payout Ratio
G9Pharma Co Ltd
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for G9Pharma Co Ltd is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
G9Pharma Co Ltd
| Average Annual Return |
N/A
|
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -89% |
| Market Capitalization | 436.4m KRW |
| Shares Outstanding | 205 862 |
| Percentage of Shares Shorted |
N/A
|
Return Decomposition
Main factors of price return
Stock Splits
G9Pharma Co Ltd's latest stock split occurred on Nov 25, 2021
The company executed a 1-for-20 stock split, meaning that for every 20 shares held, investors received 1 new share.
Before the split, G9Pharma Co Ltd traded at 315 per share. Afterward, the share price was about 6780.
The adjusted shares began trading on Nov 25, 2021. This was stock split number 4 in G9Pharma Co Ltd's history, following the previous one in Sep 21, 2020.
